The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma
Year: 2026
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Authors: Navin Pinto, Annette Künkele, Catherine M. Albert, Mallory R. Taylor, Heidi B. Ullom, Nicholas A. Vitanza, Ashley L. Wilson, Bonnie L. Cole, Cecilia C.S. Yeung, Jocelyn H. Wright, Wenjun Huang, Jason Wendler, Kristy Seidel, Christopher Brown, Joshua Gustafson, Stephanie D. Rawlings-Rhea, Adam Beebe, Stephanie Mgebroff, Rebecca A. Gardner, Michael C. Jensen, Julie R. Park
Institutions: Seattle Children's Hospital, University of Washington, Children's Hospital Colorado, Seattle Children's Research Institute, University of Colorado Anschutz, Humboldt-Universität zu Berlin, Deutsches Konsortium für Translationale Krebsforschung, Charité - Universitätsmedizin Berlin, Fred Hutch Cancer Center, St. Jude Children's Research Hospital
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7165139415